← Leaderboards
John A Belperio
University Of California Los Angeles
$13,746,778
Attributed
$24,535,331
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,535,331 · 8
By mechanism
U01$16,759,083 · 2
R01$4,166,945 · 2
P01$2,272,551 · 1
K08$608,850 · 1
T32$530,877 · 1
U10$197,025 · 1
Top collaborators
- Scott M Palmer6 shared
- Stuart C Sweet5 shared
- Robert Damoiseaux4 shared
- Brigitte N Gomperts4 shared
- Tomas Ganz1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Julio L. Vergara$6,643,550
- David Abram Zisman$767,837
Others in their field
Top investigators on “Chronic”
- Judith S. Currier · University Of California Los Angeles$245,012,139
- Lawrence Corey · Fred Hutchinson Cancer Center$209,947,290
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$201,828,077
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$173,476,538
- John M Lachin · George Washington University$125,152,883
- David M Nathan · Massachusetts Institute Of Technology$120,438,756
Research focus
ChronicLungLung TransplantationFunctional DisorderInflammatoryAllograftingPreventLung DiseasesLung AllograftMediatingBiologyTransplantationSignal TransductionAcuteBaseTissuesBronchiolitis ObliteransAffectClinical TrialsSyndromeTransplant RecipientsCellsAlveolarBiological
Grant awards (33)
Lung Transplant Clinical Trial Network (LT-CTN)$3,897,643
U01 · FY2025 · AI
The UCLA Pulmonary and Critical Care Medicine Scientist Training Program (PCCM-STP)$530,877
T32 · FY2025 · HL · contact PI
Lung Transplant Clinical Trial Network (LT-CTN)$297,730
U01 · FY2025 · AI
Lung Transplant Clinical Trial Network (LT-CTN)$1,266,035
U01 · FY2024 · AI
Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis$617,814
U01 · FY2024 · HL
Lung Transplant Clinical Trial Network (LT-CTN)$2,973,990
U01 · FY2023 · AI
Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis$630,424
U01 · FY2023 · HL
Lung Transplant Clinical Trial Network (LT-CTN)$2,975,390
U01 · FY2022 · AI
Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis$630,424
U01 · FY2022 · HL
Epithelial Progenitor Cell Dysfunction in the Fibroproliferative Process of CLAD$468,000
P01 · FY2022 · HL · contact PI
Lung Transplant Clinical Trial Network (LT-CTN)$2,981,212
U01 · FY2021 · AI
Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis$488,421
U01 · FY2021 · HL
Epithelial Progenitor Cell Dysfunction in the Fibroproliferative Process of CLAD$468,000
P01 · FY2021 · HL · contact PI
Epithelial Progenitor Cell Dysfunction in the Fibroproliferative Process of CLAD$468,000
P01 · FY2020 · HL · contact PI
Epithelial Progenitor Cell Dysfunction in the Fibroproliferative Process of CLAD$468,000
P01 · FY2019 · HL · contact PI
Epithelial Progenitor Cell Dysfunction in the Fibroproliferative Process of CLAD$400,551
P01 · FY2018 · HL · contact PI
Immune Mechanisms of Alloinjury$447,952
R01 · FY2016 · HL · contact PI
Immune Mechanisms of Alloinjury$441,231
R01 · FY2015 · HL · contact PI
Immune Mechanisms of Alloinjury$438,993
R01 · FY2014 · HL · contact PI
Immune Mechanisms of Alloinjury$426,451
R01 · FY2013 · HL · contact PI
Immune Mechanisms of Alloinjury$447,952
R01 · FY2012 · HL · contact PI
The Role of Chemokines During Lung Allograft Dysfunction$329,610
R01 · FY2009 · HL · contact PI
The Role of Chemokines During Lung Allograft Dysfunction$288,456
R01 · FY2009 · HL · contact PI
UCLA IPF Clinical Research Network$197,025
U10 · FY2009 · HL · contact PI
The Role of Chemokines During Lung Allograft Dysfunction$329,610
R01 · FY2008 · HL · contact PI
The Role of Chemokines During Lung Allograft Dysfunction$329,610
R01 · FY2007 · HL · contact PI
The Role of Chemokines During Lung Allograft Dysfunction$339,455
R01 · FY2006 · HL · contact PI
The Role of Chemokines During Lung Allograft Dysfunction$347,625
R01 · FY2005 · HL
CHEMOKINE BIOLOGY IN BRONCHIOLITIS OBLITERANS SYNDROME$121,770
K08 · FY2005 · HL
CHEMOKINE BIOLOGY IN BRONCHIOLITIS OBLITERANS SYNDROME$121,770
K08 · FY2004 · HL
CHEMOKINE BIOLOGY IN BRONCHIOLITIS OBLITERANS SYNDROME$121,770
K08 · FY2003 · HL
CHEMOKINE BIOLOGY IN BRONCHIOLITIS OBLITERANS SYNDROME$121,770
K08 · FY2002 · HL
CHEMOKINE BIOLOGY IN BRONCHIOLITIS OBLITERANS SYNDROME$121,770
K08 · FY2001 · HL